Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 1 of 1 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/11/19
End: 03/28/22
Due: 03/28/23
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Letermovir Treatment for Refractory or Resistant Cytomegalovirus Infection | NCT03728426 | Amy C. Sherman, MD | user2@example.com | None | 2019-01-11 | 2022-03-28 | 2023-03-28 | - | - | 2025-07-14 |